Nabil Elhadi Omar

Nabil Elhadi Omar is a Clinical Pharmacist specializing in Oncology and Palliative Care at Hamad Medical Corporation since April 2012, where responsibilities include medication reconciliation, advisory roles in medical rounds, patient monitoring, discharge medication counseling, and involvement in research projects. Nabil also possesses experience as an Investor at Mnbaa, contributing to the development of Arabic content and marketing strategies from January 2014 to July 2015. Prior roles include Registered Pharmacist at the Saudi Commission for Health Specialties focusing on risk evaluation for REVLIMID, Hospital Pharmacist at Dr. Soliman Fakeeh Hospital, Shift Manager at El-EZABY Pharmacies Chain, and Hospital Pharmacist at the Oncology Center of Mansoura University Hospitals. Nabil holds multiple degrees, including a Doctor of Pharmacy from Qatar University and a specific focus on Cancer Biology & Therapeutics from Harvard Medical School, along with certifications from the American Society of Health-System Pharmacists and the Institute of Healthcare Improvement.